After-Hours Movers 6/26: IPCM, ANDE, FINL, BRL Higher; PALM, KBH, TIBX Lower

June 26, 2008 5:50 PM EDT

StreetInsider.com After-Hours Movers:

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) 15.3% HIGHER; has signed a definitive agreement to acquire Hospitalists of America (HOA), headquartered in Coral Gables, Florida. Subject to completion of due diligence and other customary closing conditions, the acquisition is scheduled to close in the third quarter of 2008.Terms of the deal were not disclosed.

The Andersons, Inc. (Nasdaq: ANDE) 13.1% HIGHER; today announced that it expects its FY08 EPS to exceed previous guidance: the company now sees EPS in the range of $4.40-$4.80, up from the previous estimate of $3.65 to $4.00. The Street consensus is currently $3.79.

Finish Line (Nasdaq: FINL) 6.6% HIGHER; reports Q1 EPS of $0.02, 7 cents better than the analyst estimate of ($0.05). Revenues for the quarter were $287.9 million, versus the consensus of $281.34 million.

Palm, Inc. (Nasdaq: PALM) 4.4% LOWER; reports Q4 loss of $0.22, 4 cents below the analyst estimate of ($0.18). Revenues for the quarter were $296.2 million, versus the consensus of $301.11 million.

Barr Pharmaceuticals, Inc. (NYSE: BRL) 3.4% HIGHER; announced that U.S. District Court for Delaware has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Boehringer Ingelheim Pharmaceuticals, Inc. in connection with Boehringer Ingelheim's Mirapex(R) Tablets (pramipexole dihydrochloride) 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg. In his ruling, District Court Judge Joseph J. Farnan, Jr. found that the patent claims at issue in the litigation were invalid on the grounds of nonstatutory double patenting.

AK Steel Holding Corp. (NYSE: AKS) 3.4% HIGHER; will replace Countrywide Financial Corp. (NYSE: CFC).

KB Home (NYSE: KBH) 2.6% LOWER; trading lower ahead of its Q2 earnings report, expected out tomorrow before the market opens.

TIBCO Software (Nasdaq: TIBX) 1.6% LOWER; reports Q2 EPS of $0.07, 1 cent better than the analyst estimate of $0.06. Revenues for the quarter were $150 million, versus the consensus of $147.99 million.


Related Categories

Special Reports

Stocks Mentioned

AKS 18.04

+0.00 +0.00%
Volume: 14,927,374
Track AKS

ANDE 30.95

+0.00 +0.00%
Volume: 468,884
Track ANDE

BRL 61.60

+0.00 +0.00%
Volume: 4,164,911
Track BRL

CFC 4.25

+0.00 +0.00%
Volume: 0
Track CFC

FINL 7.84

+0.00 +0.00%
Volume: 1,873,290
Track FINL

IPCM 20.20

+0.00 +0.00%
Volume: 234,729
Track IPCM

KBH 18.03

+0.00 +0.00%
Volume: 7,900,321
Track KBH

PALM 5.80

+0.00 +0.00%
Volume: 3,018,465
Track PALM

TIBX 6.57

+0.00 +0.00%
Volume: 2,609,338
Track TIBX


Add Your Comment